跳至主要内容
临床试验/NCT01172145
NCT01172145已完成3 期

Treatment of Apathy in Alzheimer's Disease With Modafinil

Brown University1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2005年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
22
试验地点
1
主要终点
Apathy

研究概览

简要总结

This study examined the effects of modafinil on apathetic symptomatology, performance of activities of daily living (ADLs) and caregiver burden in individuals with Alzheimer's disease (AD).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 95 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of mild to moderate stage Probable Alzheimer's disease
  • on a stable dose of a cholinesterase inhibitor medication for at least 30 days
  • clinically elevated levels of apathy as measured by the Frontal Systems Behavior Scale

排除标准

  • diagnosis of Major Depression
  • focal brain lesion on neuroimaging
  • history of significant substance abuse
  • history of significant head trauma with loss if consciousness >10 minutes

研究组 & 干预措施

Cholinesterase inhibitor only

Placebo Comparator

干预措施: Placebo (Drug)

Cholinesterase Plus Modafinil

Experimental

干预措施: Modafinil (Drug)

结局指标

主要结局

Apathy

时间窗: after 8 weeks of treatment

The Frontal Systems Behavior Scale.Raw scores are converted to T-Scores using published norms. T-Scores have a mean of 50 and a standard deviation of 10. T-scores less than or equal to 64 are within the average range. T-scores equal to or greater than 65 are indicative of a clinically significant problem. Higher scores indicate greater problem severity.

次要结局

  • Lawton Brody Activities of Daily Living Questionnaire(after 8 weeks of treatment)
  • The Direct Assessment of Functional Status Scale(after 8 weeks of treatment)
  • Zarit Burden Inventory(after 8 weeks of treatment)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验